VivoPower Advances US$180 Million Non-Binding Takeover with Successful Completion of First Phase of Due Diligence

Stock Information for AnPac Bio-Medical Science Co. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AnPac Bio-Medical Science Co. Ltd.

VivoPower Advances US$308 Million Direct NASDAQ Spin-Off of Caret Digital
VivoPower Announces Key Leadership Recruits
VivoPower and Flare Launch Definitive Strategic Partnership to Deploy US$100 Million in XRP for Institutional Yield
VivoPower Sets Record Date for Special Dividend Distributions Relating to Tembo Transactions
VivoPower Advances US$200 Million Tembo Transaction Following Completion of Second Phase of Due Diligence by Energi Holdings
BitGo Enters Strategic Partnership with VivoPower to Facilitate its Initial $100 Million XRP Acquisition for Treasury Strategy
BitGo Enters Strategic Partnership with VivoPower to Facilitate its Initial US$100 Million XRP Acquisition for Treasury Strategy
CORRECTION: VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement Priced at US$6.05 Per Share, Above Last Market Closing Price Under NASDAQ Rules

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.